Category:
Peptides
CAS NO:
910463-68-2
Standard:
In-house Standards,

Semaglutide is a long-acting GLP-1 receptor agonist (GLP-1RA)
administered once a week. By inhibiting the DPP-4 enzyme, it
extends the half-life of GLP-1 receptors, enhances insulin
secretion in a glucose-dependent manner, suppresses glucagon
secretion, and slows gastric emptying, ultimately reducing blood
sugar levels. Additionally, Semaglutide has effects on weight
loss, glycemic control, and cardiovascular benefits. It also
inhibits appetite, reducing food intake to achieve weight
reduction